StockData
Vaxcyte, Inc. logo

Vaxcyte, Inc. (PCVX) stock

PCVXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$58.52−0.88 (-1.48%)

Close on Nov 18, 2026Market cap $8.71BP/E –Yield 0.00%

Vaxcyte gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Vaxcyte

Vaxcyte has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Vaxcyte figures

See a number that looks wrong?